On June 3rd, CDRD hosted our global partners including the US National Institutes of Health (NIH), the European Infrastructure for Translational Medicine (EATRIS), Therapeutic Innovation Australia and MRC Technology (UK).
On May 26th, CDRD hosted a partnership appreciation lunch and open house. Thank you to everyone for your ongoing support!
Quark Venture has made a significant seed investment in Sitka Biopharma – a critical value-creating event that will enable Sitka to advance their lead compound for the treatment of bladder cancer into clinical trials.
In total, over one-third of all the life science companies included in the 2016 Ready to Rocket and Emerging Rocket Life Sciences lists have received support, mentorship and/or expertise from CDRD.
CDRD is a proud sponsor of the 16th IUBMB Conference in Vancouver, from July 17-21, 2016.
Health sciences researchers, entrepreneurs, and companies alike have the opportunity to collaborate with CDRD and thereby access its full suite of expertise, infrastructure, and broad partnerships and networks.
Introducing Zucara Therapeutics Inc., a new start-up company created by MaRS Innovation and CDRD.
Zucara is developing a novel drug therapy to reduce the severity and frequency of hypoglycemic (low blood sugar) episodes in people with diabetes.
CDRD BY THE NUMBERS:
Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.
We work in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.
In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country.
Since 2008, Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).